M&A Deal Summary

Hologic Acquires Bolder Surgical

On October 14, 2021, Hologic acquired medical products company Bolder Surgical for 160M USD

Acquisition Highlights
  • This is Hologic’s 18th transaction in the Medical Products sector.
  • This is Hologic’s 11th largest (disclosed) transaction.
  • This is Hologic’s 17th transaction in the United States.
  • This is Hologic’s 1st transaction in Colorado.

M&A Deal Summary

Date 2021-10-14
Target Bolder Surgical
Sector Medical Products
Buyer(s) Hologic
Deal Type Add-on Acquisition
Deal Value 160M USD

Target

Bolder Surgical

Louisville, Colorado, United States
Bolder Surgical is a developer and producer of precisely designed surgical instruments that allow access to confined structures found in pediatric and other surgical procedures. Bolder Surgical was founded in 2010 and is based in Louisville, Colorado.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States

Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 23 of 25
Sector (Medical Products) 18 of 19
Type (Add-on Acquisition) 21 of 23
State (Colorado) 1 of 1
Country (United States) 17 of 18
Year (2021) 5 of 5
Size (of disclosed) 11 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-08 Mobidiag

Espoo, Finland

Mobidiag is a biotech company specializing in rapid diagnostics of infectious diseases. The company develops and sells fast and accurate molecular diagnostic assays for the diagnosis of pathogenic microbes causing severe infections. Mobidiag was founded in 2000 and is based in Espoo, Finland.

Buy $795M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-29 Endomagnetics

Cambridge, United Kingdom

Endomagnetics develops and sells breast surgery localization and lymphatic tracking technologies. Endomagnetics is based in Cambridge, United Kingdom.

Buy $310M